SCHEMBL31246170

SCHEMBL31246170

CC(C)(C)[Si](C)(C)OCCCOc1ccc(Cl)cc1C(=O)O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 2/20 0.50
TSHR P16473 1/20 0.50
ALDH1A1 P00352 4/20 0.46
SMN1; SMN2 Q16637 4/20 0.46
LMNA P02545 2/20 0.46
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
KDM4E B2RXH2 5/20 0.44
MAPK1 P28482 1/20 0.42
MRGPRX4 Q96LA9 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
PTPN11 Q06124 2/20 0.41
MAPT P10636 3/20 0.41
NPC1 O15118 2/20 0.41
RAB9A P51151 2/20 0.41
CYP1A2 P05177 2/20 0.40
CYP2C19 P33261 2/20 0.40
CYP2D6 P10635 1/20 0.40
CYP2C9 P11712 1/20 0.40
HPGD P15428 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16146836 0.89 ALDH1A1 (0.42) GAATSHRALDH1A1SMN1; SMN2LMNA
SCHEMBL31246228 0.88 MAPT (0.44) ALDH1A1SMN1; SMN2LMNAMEN1KMT2A
SCHEMBL16146968 0.82 NPC1 (0.43) GAATSHRALDH1A1SMN1; SMN2LMNA
SCHEMBL6420140 0.81 S1PR4 (0.47) ALDH1A1SMN1; SMN2LMNAMEN1KMT2A
SCHEMBL13125271 0.80 RXRA (0.47) GAAALDH1A1SMN1; SMN2LMNAMEN1
SCHEMBL16696146 0.80 KDM4E (0.45) GAAALDH1A1SMN1; SMN2LMNAMEN1
SCHEMBL358928 0.79 MAPT (0.42) GAAALDH1A1SMN1; SMN2LMNAMEN1
SCHEMBL1153890 0.78 GAA (0.60) GAATSHRALDH1A1MEN1KMT2A
SCHEMBL20522075 0.77 GAA (0.61) GAATSHRALDH1A1LMNAMRGPRX4
SCHEMBL358808 0.77 S1PR4 (0.53) ALDH1A1SMN1; SMN2LMNAMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4713320-A2 BCAT2 INHIBITORS Agios Pharmaceuticals, Inc. (US) 2026-03-25 EP disclosed
WO-2024238820-A2 BCAT2 INHIBITORS AGIOS PHARMACEUTICALS, INC. (US) 2024-11-21 WO disclosed